![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Atul Limited Valsad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their significant offerings is Dapsone, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2015-177 - Rev 00
This Chemical Type CEP, issued on March 21, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 77 associated with this CEP further emphasizes